awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q58566132-99BBC00D-1FF6-4C5F-9A65-DD7F48920F81
Q58566132-99BBC00D-1FF6-4C5F-9A65-DD7F48920F81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58566132-99BBC00D-1FF6-4C5F-9A65-DD7F48920F81
The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease
P2860
Q58566132-99BBC00D-1FF6-4C5F-9A65-DD7F48920F81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58566132-99BBC00D-1FF6-4C5F-9A65-DD7F48920F81
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0fd75161b070b280bd80b669f418ad711d215d97
P2860
The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease